AJP Rep 2016; 06(03): e260-e263
DOI: 10.1055/s-0036-1585578
Case Report
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Infantile Hepatic Hemangioendothelioma: An Uncommon Cause of Persistent Pulmonary Hypertension in a Newborn Infant

Trassanee Chatmethakul
1   Department of Pediatrics, University of South Alabama, Mobile, Alabama
,
Ramachandra Bhat
1   Department of Pediatrics, University of South Alabama, Mobile, Alabama
,
Maryam Alkaabi
1   Department of Pediatrics, University of South Alabama, Mobile, Alabama
,
Abdul Siddiqui
1   Department of Pediatrics, University of South Alabama, Mobile, Alabama
,
Keith Peevy
1   Department of Pediatrics, University of South Alabama, Mobile, Alabama
,
Michael Zayek
1   Department of Pediatrics, University of South Alabama, Mobile, Alabama
› Institutsangaben
Weitere Informationen

Publikationsverlauf

01. Februar 2016

31. Mai 2016

Publikationsdatum:
22. Juli 2016 (online)

Abstract

Multifocal and diffuse infantile hepatic hemangioendotheliomas commonly present with signs of high-output congestive heart failure. In addition, prolonged persistent pulmonary overcirculation eventually leads to the development of pulmonary hypertension at a later age. We report a 2-day old, full-term infant with multifocal, large infantile hepatic hemangioendothelioma, who presented with an early onset of pulmonary hypertension, managed successfully with supportive care and systemic therapy directed toward the involution of infantile hepatic hemangioendothelioma.

 
  • References

  • 1 Steinhorn RH. Neonatal pulmonary hypertension. Pediatr Crit Care Med 2010; 11 (2, Suppl) S79-S84
  • 2 Jain A, McNamara PJ. Persistent pulmonary hypertension of the newborn: advances in diagnosis and treatment. Semin Fetal Neonatal Med 2015; 20 (4) 262-271
  • 3 Obeid R, Kalra VK, Arora P, Quist F, Moltz KC, Chouthai NS. Neonatal thyrotoxicosis presenting as persistent pulmonary hypertension. BMJ Case Rep 2012; 2012: 5939
  • 4 Hendson L, Emery DJ, Phillipos EZ, Bhargava R, Olley PM, Lemke RP. Persistent pulmonary hypertension of the newborn presenting as the primary manifestation of intracranial arteriovenous malformation of the Vein of Galen. Am J Perinatol 2000; 17 (8) 405-410
  • 5 Selzer G, Rettwitz-Volk W, Schloesser R , et al. Persistent pulmonary hypertension in the newborn infant caused by aneurysm of the vein of Galen [in German]. Klin Padiatr 1993; 205 (3) 190-193
  • 6 Huh J, Noh CI, Choi JY, Yun YS. Pulmonary hypertensive crisis as an initial manifestation of intracranial arteriovenous malformation with aneurysm of the vein of Galen. Int J Cardiol 1998; 66 (1) 107-109
  • 7 Alexander CP, Sood BG, Zilberman MV, Becker C, Bedard MP. Congenital hepatic arteriovenous malformation: an unusual cause of neonatal persistent pulmonary hypertension. J Perinatol 2006; 26 (5) 316-318
  • 8 Kim EH, Koh KN, Park M, Kim BE, Im HJ, Seo JJ. Clinical features of infantile hepatic hemangioendothelioma. Korean J Pediatr 2011; 54 (6) 260-266
  • 9 Long WA, Schall SA, Henry GW. Cerebral arteriovenous malformation presenting as persistent fetal circulation. Diagnosis by cross-sectional echo. Am J Perinatol 1984; 1 (3) 236-241
  • 10 Daller JA, Bueno J, Gutierrez J , et al. Hepatic hemangioendothelioma: clinical experience and management strategy. J Pediatr Surg 1999; 34 (1) 98-105 , discussion 105–106
  • 11 Emmanouilides GC, Moss AJ, Duffie Jr ER, Adams FH. Pulmonary arterial pressure changes in human newborn infants from birth to 3 days of age. J Pediatr 1964; 65: 327-333
  • 12 Gao Y, Raj JU. Regulation of the pulmonary circulation in the fetus and newborn. Physiol Rev 2010; 90 (4) 1291-1335
  • 13 Rudolph AM. The changes in the circulation after birth. Their importance in congenital heart disease. Circulation 1970; 41 (2) 343-359
  • 14 Alano MA, Ngougmna E, Ostrea Jr EM, Konduri GG. Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn. Pediatrics 2001; 107 (3) 519-523
  • 15 Morin III FC. Ligating the ductus arteriosus before birth causes persistent pulmonary hypertension in the newborn lamb. Pediatr Res 1989; 25 (3) 245-250
  • 16 Selby DM, Stocker JT, Waclawiw MA, Hitchcock CL, Ishak KG. Infantile hemangioendothelioma of the liver. Hepatology 1994; 20 (1 Pt 1) 39-45
  • 17 Lowe LH, Marchant TC, Rivard DC, Scherbel AJ. Vascular malformations: classification and terminology the radiologist needs to know. Semin Roentgenol 2012; 47 (2) 106-117
  • 18 Wassef M, Blei F, Adams D , et al; ISSVA Board and Scientific Committee. Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics 2015; 136 (1) e203-e214
  • 19 Kuroda T, Kumagai M, Nosaka S, Nakazawa A, Takimoto T, Hoshino K ; Infantile Hepatic Hemangioma Study Group, Japan. Critical infantile hepatic hemangioma: results of a nationwide survey by the Japanese Infantile Hepatic Hemangioma Study Group. J Pediatr Surg 2011; 46 (12) 2239-2243
  • 20 Christison-Lagay ER, Burrows PE, Alomari A , et al. Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg 2007; 42 (1) 62-67 , discussion 67–68
  • 21 Buonomo C, Taylor GA, Share JC, Kirks DR. Abnormalities of the hepatobiliary system. In: Kirks DR, Griscom TN, eds. Practical Pediatric Imaging: Diagnostic Radiology of Infants and Children. 3rd ed. Philadelphia. PA: Lippincott-Raven; 1998: 954-979
  • 22 Sevinir B, Ozkan TB. Infantile hepatic hemangioendothelioma: clinical presentation and treatment. Turk J Gastroenterol 2007; 18 (3) 182-187
  • 23 Bosemani T, Puttgen KB, Huisman TA, Tekes A. Multifocal infantile hepatic hemangiomas—imaging strategy and response to treatment after propranolol and steroids including review of the literature. Eur J Pediatr 2012; 171 (7) 1023-1028
  • 24 Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J , et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med 2015; 372 (8) 735-746
  • 25 Avagyan S, Klein M, Kerkar N , et al. Propranolol as a first-line treatment for diffuse infantile hepatic hemangioendothelioma. J Pediatr Gastroenterol Nutr 2013; 56 (3) e17-e20